UK - The Institute of Directors has launched a new qualification aimed at boosting corporate governance standards in the pharmaceutical industry.
The IoD’s Company Direction Programme will, for the first time, be tailored to the needs of industry leaders, covering directors’ responsibilities and strategies to improve business performance.
The diploma – a collaboration between the IoD and the Association of the British Pharmaceutical Industry – will also encourage the formation of a peer level network offering support to directors.
IoD director general George Cox said: “Pressure grows continuously for a high level of professionalism in the boardroom – the IoD’s Company Direction Programme is a major contributor towards equipping directors in this field.”
The programme is structured as a series of eight workshop modules, ranging from one to three days, to be taken over two years. Subjects covered include finance, law and marketing specifically in the context of the pharmaceutical industry, with completion of the diploma leading to eligibility for the IoD’s professional qualification, chartered director.
Ex-BHS owner Dominic Chappell has been ordered to pay a total of £87,000 in fines and court costs after he was found guilty of failing to provide The Pensions Regulator (TPR) with information.
The Department for Work and Pensions (DWP) has said it while believes in the benefits of consolidating defined benefit (DB) schemes, there are significant issues to overcome.
There is just one week left to register to enter the Workplace Savings and Benefits Awards 2018.
Nearly a third (32%) of employers believe new technologies, such as augmented and virtual reality, will play a part in benefits communications, latest research from Aon Employee Benefits reveals.